GSK licenses rights to Human Genome Sciences' Albugon
In its largest deal yet, Human Genome Sciences licensed GlaxoSmithKline exclusive worldwide development and commercialization rights to Albugon (albumin GLP-1) for all therapeutic and prophylactic applications.
- Large Molecule
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.